Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nutra Pharma Corp (OP: NPHC )

0.0091 USD +0.0006 (+7.06%)
Official Closing Price Updated: 4:02 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Nutra Pharma Corp

Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications
Tags Pet Pain Away Network Small Business
From OTC
Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys
Tags Branding Online Manufacturing
From OTC
Nutra Pharma Letter to Shareholders
Tags Online OTC Markets NPHC
From OTC
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
Tags Manufacturing NPHC OTC Markets
From OTC
Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace
Tags OTC Markets NPHC OTC
From OTC
Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt
Tags OTC PR WIRE Nyloxin OTC
From OTC
Biotech Stocks-More OTC Pain Alternatives see Continued Growth $INNV (OTCMKTS: INNV) $PFNX (NYSE: PFNX) $HRTX (NASDAQ: HRTX) $NPHC
Tags Biotech Investment Consumer
From Issuewire
Nutra Pharma Announces that Nyloxin is Now Available on the iRemedy Marketplace
The iRemedy Healthcare Companies, an industry leader in ecommerce medical supplies and medical business consulting, announced the addition of the Nyloxin® line of pain relief products to their... 
From GlobeNewswire News Releases
Nutra Pharma Responds to FDA Warning Letter
Nutra Pharma has provided a response to the FDA warning letter sent to the company on March 11, 2019 regarding Nutra Pharma’s homeopathic drug, Nyloxin® 
From GlobeNewswire News Releases
Nutra Pharma Comments on SEC Complaint
via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today. 
From GlobeNewswire News Releases
Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service-Disabled Veteran-Owned Small Business for Sales through GoVets.com
Nutra Pharma is providing an update on the work of EuroAmerican IP, LLC to create awareness and sales into military and governmental buyers 
From GlobeNewswire News Releases
Nutra Pharma Announces Agreement to Launch Comprehensive Internet Marketing Campaign
via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that it has... 
From GlobeNewswire News Releases
Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand
Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that DEG Productions has signed... 
From GlobeNewswire News Releases
Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing
via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing... 
From GlobeNewswire News Releases
Nutra Pharma Announces Direct Response Television Campaign for Pet Pain-Away™
via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that DEG... 
From GlobeNewswire News Releases
Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution
Nutra Pharma is partnering with NxGen Brands, LLC to market and distribute their Over-the-Counter (OTC) pain reliever, Nyloxin® through all of their distribution channels 
From GlobeNewswire News Releases
Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing... 
From GlobeNewswire News Releases
Nutra Pharma Announces Corporate Updates
Nutra Pharma is announcing today the first of several restructuring steps that will expand the Company’s core business strengths, restructure debt as well as increase its reach into important... 
From GlobeNewswire News Releases
Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures
via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing... 
From GlobeNewswire News Releases
Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
Nutra Pharma has announced that they have signed a definitive Distribution Agreement with Pharmachal PTY LTD to distribute Nyloxin® in Australia and New Zealand 
From GlobeNewswire News Releases
Nutra Pharma Unveils Updated Websites
Nutra Pharma Corporation is inviting visitors to explore its new websites at www.nutrapharma.com and www.nyloxin.com. The new websites have been designed to provide the ultimate user-friendly... 
From GlobeNewswire News Releases
Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin® for Sale to Government Agencies
Nutra Pharma is partnering with EuroAmerican IP, LLC to distribute their Over-the-Counter (OTC) pain reliever, Nyloxin® Topical Gel, through EuroAmerican IP’s existing Federal Supply Schedule... 
From GlobeNewswire News Releases
Nutra Pharma Letter to Shareholders
Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company 
From GlobeNewswire News Releases
New Edition of Textbook on Treating Canine Arthritis Includes Nutra Pharma Pain Remedy
As the latest class of Veterinary Doctors begins their training, a textbook used by Veterinary Schools on the treatment of arthritis in dogs refers to Nutra Pharma and their product for controlling... 
From Marketwired News Releases
Nutra Pharma Announcing Launch of Luxury Feet
Nutra Pharma is announcing the launch of Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos 
From Marketwired News Releases
Nutra Pharma Featured on Univision's Spanish-Language News Show: Primer Impacto
Nutra Pharma's over the counter (OTC) products, Nyloxin(R) and Pet Pain-Away(TM), were featured on Univision's Spanish-language news show, Primer Impacto on June 6, 2017 
From Marketwired News Releases
Nutra Pharma Announces Collaboration with the University of Maryland Bioprocess Scale-Up Facility in Preparation of Material for Phase II Studies
From Marketwired News Releases
Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures
From Marketwired News Releases
Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com
The interview provides an outline for Nutra Pharma's growth plans over the next eighteen months 
From Marketwired News Releases
Global Small Caps Initiates Coverage on Nutra Pharma
From Marketwired News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account